NCT00322829View on ClinicalTrials.gov

Development and Optimization of a GBS Diagnostic Test

CompletedOBSERVATIONAL
Enrollment

269

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Streptococcus Group B
Trial Locations (1)

G1V 4G2

Centre Hospitalier de l'Université Laval/ CHUQ, Québec

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Laval University

OTHER

NCT00322829 - Development and Optimization of a GBS Diagnostic Test | Biotech Hunter | Biotech Hunter